Foundation S will incorporate as its cornerstone initiative the former Sanofi Espoir Foundation’s ‘My Child Matters’ program in childhood cancer
The facility is among 12 centres established worldwide, and the first in Asia
Flagship U.S. facility will include biologic manufacturing and late stage research and clinical development of innovative cancer medicines
CLNK is a biotechnology research and development company that utilizes umbilical cord blood as the raw material to develop innovative, allogeneic, off-the-shelf, cell based therapeutic products
Pharma exports in 2021-22 sustain a positive growth despite global trade disruptions
Participants taking tirzepatide lost up to 52 lb. (24 kg) in this 72-week phase 3 study
Business EPS of €1.94, up 20.5% on a reported basis and 16.1% at CER, also benefitting from an improved effective tax rate
TSCS appeals to the Govt. of Telangana to release a G.O for mandatory antenatal test - HbA2 for every pregnant woman to help prevent the birth of Thalassemia Major Children for the well-being of their family & Telangana State
The demand for high-quality paediatric medicines has been growing rapidly in China as a result of the government’s support and policy measures
Beyond the technical leadership from F1, the collaboration will bring a specific focus on the people dimension of high performance
Subscribe To Our Newsletter & Stay Updated
